SOUTHWEST ONCOLOGY GROUP/UNIVERSITY OF CALIFORNIA, DAVIS
西南肿瘤学组/加州大学戴维斯分校
基本信息
- 批准号:6848158
- 负责人:
- 金额:$ 10.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-01-01 至 2004-03-31
- 项目状态:已结题
- 来源:
- 关键词:antineoplasticsbleomycinbone marrow transplantationbrain neoplasmsbreast neoplasmscancer information systemcancer preventioncancer registry /resourcecis platinum compoundclinical researchclinical trialscombination cancer therapycombination chemotherapycooperative studycyclophosphamidedoxorubicindrug resistancefemale reproductive system neoplasmfludarabinegastrointestinal neoplasmshead /neck neoplasmhormone therapyhuman subjecthuman therapy evaluationifosfamideleukemialung neoplasmslymphomameeting /conference /symposiummelanomamultiple myelomaneoplasm /cancer chemotherapyneoplasm /cancer diagnosisneoplasm /cancer epidemiologyneoplasm /cancer geneticsneoplasm /cancer immunotherapyneoplasm /cancer radiation therapyneoplasm /cancer surgeryoncology nursingpaclitaxelpancreas neoplasmspathologyprognosisprostate neoplasmsquality of lifesarcomatamoxifentissue resource /registryurinary tract neoplasmswomen&aposs health
项目摘要
Description: This is a dynamic, multicenter and multidisciplinary site with
high accrual (average 200/year, highest 2-4 percent of all SWOG
institutions) with an extensive CGOP, including the Kaiser system, and a
large VA/Air Force site. During the last cycle there have been increasing
scientific contributions, Group leadership, provision of special resources,
and pilot studies which have been translated into SWOG protocols. Despite
excellent performance, it has been functioning with less than adequate
support. This has led to several periods of a self-imposed cap on
registration until all data becomes current. The cancer program has been
designated by the University as a Center of Excellence, and the physical
facilities seem excellent. This level of activity has been maintained in an
environment of 90 percent managed care.
描述:这是一个动态,多中心和多学科站点
高应计(平均200/年,最高的2-4%
机构)具有广泛的CGOP,包括Kaiser系统和A
大型VA/空军站点。 在最后一个周期中有所增加
科学贡献,小组领导,特殊资源的提供,
以及已转化为摇摆协议的试点研究。 尽管
出色的性能,它的运作率不足
支持。 这导致了几个自我强加的帽子的时期
注册直到所有数据变为最新。 癌症计划已经
大学被指定为卓越中心和身体
设施似乎很棒。 这种活动水平已在
90%管理护理的环境。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID R GANDARA其他文献
DAVID R GANDARA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID R GANDARA', 18)}}的其他基金
TAS::75 0849::TAS EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
TAS::75 0849::TAS 早期治疗开发,重点是 II 期
- 批准号:
8352517 - 财政年份:2011
- 资助金额:
$ 10.88万 - 项目类别:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
以第二阶段为重点的早期治疗开发
- 批准号:
8845057 - 财政年份:2011
- 资助金额:
$ 10.88万 - 项目类别:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
以第二阶段为重点的早期治疗开发
- 批准号:
9038815 - 财政年份:2011
- 资助金额:
$ 10.88万 - 项目类别:
EARLY THERAPEUTICS DEVELOPMENT WITH PHASE II EMPHASIS
以第二阶段为重点的早期治疗开发
- 批准号:
8737143 - 财政年份:2011
- 资助金额:
$ 10.88万 - 项目类别:
相似海外基金
PARTICIPATE AS MEMBER OF SOUTHWEST ONCOLOGY GROUP
作为西南肿瘤学组成员参与
- 批准号:
6403175 - 财政年份:1998
- 资助金额:
$ 10.88万 - 项目类别: